“In cholesterol-loaded DCs , treatment with epinephrine significantly increased AR-β1 protein expression by 56.99±4.87%, but inhibited β-arrestin 2 and CCR7 protein expression by 30.51±4.22% and 25.31±0.04%, respectively.”
“TNF-α and MMP9 levels were decreased by 68.33±4.00% and 39.57±9.21% in cholesterol-loaded DCs treated with epinephrine.”
“The chemotactic cell numbers in cholesterol-loaded DCs treated with epinephrine were significantly decreased by 26.66±6.29% (6h), 35.67±2.91% (12h) and 29.33±1.09% (24h).”